ReleaseWire Connect

The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.

Allergy can be defined as a systemic immunological disease, wherein the immune system of the body reacts abnormally to a foreign substance. The foreign substance that triggers an allergic reaction is known as an allergen. Allergens are known to induce an immune response in human beings which are characterized by the presence of allergen-specific IgE antibodies. Allergic immunotherapy can be defined as the administration of allergen for the purpose of inducing tolerance specific to the allergen for the treatment of allergy. Allergy immunotherapy is a treatment that targets the underlying allergic disease, and affects the immunological mechanisms inducing immunologic tolerance. Allergies are caused due to exposure to various agents such as food, plants, pollen, and others. The various routes of exposure to allergens that lead to allergic reactions include inhalation, ingestion, skin contact, and injection. These allergens lead to a range of manifestations, including rhinitis, conjunctivitis, urticaria, and atopic dermatitis.

Neurovascular intervention is the use of minimally invasive medical devices and techniques to treat vascular diseases of central nervous system. Neurovascular interventional procedures help to avoid surgeries of high risk zones of body such as brain, spine, or the neck. It is a field with significant scope for research and development because it requires a highly expertise neurologist to perform the procedures with current conventional devices. There is a need to advance technology and devices to minimize the failures in interventional procedures. Neurovascular Intervention involves usage of minimally invasive approaches including the use of microcatheters to treat various diseases of the brain, head, neck, and spine. Neurovascular interventional devices are used in procedures such as removal of blood clot within a blood vessel in the brain during an acute ischemic stroke and to restore blood flow. Several improvements are noted with endovascular treatment of intracranial aneurisms by detachable coils. Recent evidence suggests that endovascular intervention is at least as effective as open surgery, with fewer complications.

The opportunity in the global transdermal scopolamine market was pegged at US$330.0 mn in 2015 and is poised to reach a valuation of US$585.3 mn by the end of 2024, progressing at a healthy CAGR of 6.70% between 2016 and 2024.

The rising demand for these plasma products and derivatives has changed the dynamics of this market, which accounted for US$1.04 bn in 2015. Analysts estimate the opportunity in this market to increase at a CAGR of 7.10% between 2016 and 2024 and reach a value of US$1.92 bn by the end of 2024.

Exhibiting a CAGR of 9.4% between 2016 and 2025, the global collagen peptide and gelatin market is forecast to reach US$11.15 bn by the end of 2025. Earlier, in 2016 it was valued at US$4.52 bn. Spurred by various factors the market is forecast to ascend at a healthy pace through the forecast period. For instance, increasing concerns among global population regarding health and wellness will be a primary market driver. Besides this, the global collagen peptide and gelatin market is expected to gain from the rising demand for dietary supplements.

Infestation of blood feeding Phthiraptera, an ectoparasitic insect (Louse) is referred as pediculosis. While sucking human blood, lice saliva enters human circulatory system which causes puritus. Lice can survive away from human host for 10 days post which it dies due to starvation. A mature female louse lay 3 to 6 eggs per day. Eggs (Nits) hatch in 8 to 10 days and reach maturity in 13 to 15 days. Mature lice live for 10 days.

According to a TMR analyst, "The global market for ultrasound devices is expected to witness a CAGR of 5.8% between 2015 and 2023. Rising from a valuation of US$6.7 bn in 2014, the market will most likely touch US$11 bn by the end of 2023."

With a larger pool of players operating domestically and a smaller bunch of international participants, the global platelet-rich plasma (PRP) market demonstrates a semi-consolidated landscape. The top five players, namely, Harvest Technologies, Arthrex Inc., Zimmer Biomet, DePuy Synthes, and Stryker Corp. accounted for more than 80% of this market in 2015. Most of these are headquartered in North America. However, their focus is likely to shift towards emerging economies across Asia Pacific in the coming years, as this region is expected to offer lucrative opportunities on account of untapped potential.

Thermo Fisher Scientific, GE Healthcare, DNA Technologies, BioAutomation, Applied Biosystems, GeneDesign, Inc., Eurofins Genomics, Integrated Kaneka Eurogentec S.A., Sigma-Aldrich Corporation, and Agilent Technologies are some of the prominent participants in the global oligonucleotide synthesis market. Among them, Thermo Fisher Scientific is a dominant player that held maximum market share in 2016. Its leading position in the global oligonucleotide synthesis market is a result of its diverse product portfolio and strong outreach. Sigma-Aldrich Corporation comes in the second position in terms of market share.